NASDAQ: OMIC
Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their OMIC stock forecasts and price targets.

Forecast return on equity

Is OMIC forecast to generate an efficient return?

Forecast return on assets

Is OMIC forecast to generate an efficient return on assets?

OMIC revenue forecast

What is OMIC's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$5.1M+91.3%
Avg 2 year Forecast
$16.3M+511.4%
OMIC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OMIC revenue growth forecast

How is OMIC forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
91.3%
Industry
8.7%
Market
20.15%
OMIC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OMIC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OMIC vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
OMIC$19.93N/AN/A
MBOT$2.55$9.00+252.94%Buy
HBIO$1.44N/AN/A
POCI$5.15N/AN/A
FEMY$1.18$10.00+747.46%Strong Buy

Singular Genomics Systems Stock Forecast FAQ

What is OMIC's revenue growth forecast for 2025-2026?

(NASDAQ: OMIC) Singular Genomics Systems's forecast annual revenue growth rate of 91.3% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 20.15%.

Singular Genomics Systems's revenue in 2025 is $2,666,000.On average, 1 Wall Street analysts forecast OMIC's revenue for 2025 to be $12,810,093, with the lowest OMIC revenue forecast at $12,810,093, and the highest OMIC revenue forecast at $12,810,093.

In 2026, OMIC is forecast to generate $40,942,063 in revenue, with the lowest revenue forecast at $40,942,063 and the highest revenue forecast at $40,942,063.

If you're new to stock investing, here's how to buy Singular Genomics Systems stock.

What is OMIC's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: OMIC) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.79%.

What is OMIC's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: OMIC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.